CT simulator debuts

Article

Philips launched a new CT simulation workstation at the 2003 annual meeting of the American Association of Physicists in Medicine held Aug. 10 to 14 in San Diego. The AcQSim3 combines simulation features of the AcQSim workstation with Philips' radiation

Philips launched a new CT simulation workstation at the 2003 annual meeting of the American Association of Physicists in Medicine held Aug. 10 to 14 in San Diego. The AcQSim3 combines simulation features of the AcQSim workstation with Philips' radiation therapy planning (RTP) system Pinnacle3, creating a single shared platform and integrated workflow. Integration of the CT simulation workstation and RTP enables access to shared patient data from other Philips oncology workstations. The new AcQSim3 connects seamlessly to the company's image fusion application, Syntegra, and intensity-modulated radiation therapy application, P3IMRT. It is compatible with Philips' multimodality imaging systems, including the AcQSim CT, Gemini PET/CT, and Panorama MRI, as well as with other vendors' DICOM-compliant imaging systems. AcQSim3 can also communicate with other vendors' RTP systems via standard DICOM and DICOM-RT transfer protocols.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.